Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus : a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Schulte, C., Barwari, T. et al. (6 more authors) (2020) Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus : a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels. Cardiovascular Diabetology, 19 (1). 3.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
Keywords: Aspirin; Diabetes mellitus; Micro RNA; P2Y12 inhibitors; Platelet inhibition
Dates:
  • Accepted: 26 December 2019
  • Published (online): 7 January 2020
  • Published: December 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 25 Feb 2020 14:12
Last Modified: 25 Feb 2020 21:38
Status: Published
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/s12933-019-0981-3
Related URLs:

Share / Export

Statistics